Enabling endpoint development for interventional clinical trials in individuals with Angelman syndrome: a prospective, longitudinal, observational clinical study (FREESIAS).

Tjeertes J, Bacino CA, Bichell TJ, Bird LM, Bustamante M, Crean R, Jeste S, Komorowski RW, Krishnan ML, Miller MT, Nobbs D, Ochoa-Lubinoff C, Parkerson KA, Rotenberg A, Sadhwani A, Shen MD, Squassante L, Tan WH, Vincenzi B, Wheeler AC, Hipp JF, Berry-Kravis E

Open source

DOI: 10.1186/s11689-023-09494-w
Published: 2023 Jul 26
Container: Journal of neurodevelopmental disorders
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s11689-023-09494-w,
  title = {Enabling endpoint development for interventional clinical trials in individuals with Angelman syndrome: a prospective, longitudinal, observational clinical study (FREESIAS).},
  author = {Tjeertes J and Bacino CA and Bichell TJ and Bird LM and Bustamante M and Crean R and Jeste S and Komorowski RW and Krishnan ML and Miller MT and Nobbs D and Ochoa-Lubinoff C and Parkerson KA and Rotenberg A and Sadhwani A and Shen MD and Squassante L and Tan WH and Vincenzi B and Wheeler AC and Hipp JF and Berry-Kravis E},
  year = {2023},
  journal = {Journal of neurodevelopmental disorders},
  doi = {10.1186/s11689-023-09494-w},
  url = {https://doi.org/10.1186/s11689-023-09494-w}
}

RIS

TY  - JOUR
TI  - Enabling endpoint development for interventional clinical trials in individuals with Angelman syndrome: a prospective, longitudinal, observational clinical study (FREESIAS).
AU  - Tjeertes J
AU  - Bacino CA
AU  - Bichell TJ
AU  - Bird LM
AU  - Bustamante M
AU  - Crean R
AU  - Jeste S
AU  - Komorowski RW
AU  - Krishnan ML
AU  - Miller MT
AU  - Nobbs D
AU  - Ochoa-Lubinoff C
AU  - Parkerson KA
AU  - Rotenberg A
AU  - Sadhwani A
AU  - Shen MD
AU  - Squassante L
AU  - Tan WH
AU  - Vincenzi B
AU  - Wheeler AC
AU  - Hipp JF
AU  - Berry-Kravis E
PY  - 2023
JO  - Journal of neurodevelopmental disorders
DO  - 10.1186/s11689-023-09494-w
UR  - https://doi.org/10.1186/s11689-023-09494-w
ER  -

APA

J, T., CA, B., TJ, B., LM, B., M, B., R, C., S, J., RW, K., ML, K., MT, M., D, N., C, O., KA, P., A, R., A, S., MD, S., L, S., WH, T., B, V., AC, W., JF, H., & E, B. (2023). Enabling endpoint development for interventional clinical trials in individuals with Angelman syndrome: a prospective, longitudinal, observational clinical study (FREESIAS).. Journal of neurodevelopmental disorders. https://doi.org/10.1186/s11689-023-09494-w

Source records

pubmed · retrieved 2026-09-27T10:03:47.001Z